The latest report by IMARC Group, titled “United States Immunoassay Market Report by Technology (Radioimmunoassay, Enzyme Immunoassay, Rapid Test, and Others), Product (Reagents and Kits, Analyzers/Instruments, Software and Services), Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, and Others), End Use (Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical and Biotech Companies, Academic Research Centers, and Others), and Region 2024-2032” The study provides a detailed analysis of the industry, including the United States Immunoassay market share, size, growth, trends, price and forecasts. The market size is projected to exhibit a growth rate (CAGR) of 8.00% during 2024-2032.

United States Immunoassay Market Trends:

Immunoassay is a laboratory technique used to detect and quantify specific substances, such as hormones, drugs, or proteins, based on their interaction with antibodies. It relies on the highly specific binding between an antibody and its target molecule. It is widely available in various formats, including enzyme-linked immunosorbent assays (ELISA), radioimmunoassay (RIA), and chemiluminescent immunoassays (CLIA). It plays a crucial role in detecting diseases, monitoring therapeutic drug levels, and ensuring product quality and safety. It requires only a small volume of samples, minimizing patient discomfort and risk. It undergoes rigorous validation processes, ensuring reliability and reproducibility of results. It offers high specificity and can accurately identify target molecules amidst a complex sample matrix. It provides rapid results, enabling timely decision-making in various applications. As it assists in ensuring that patients receive the correct dosage within the therapeutic range, the demand for immunoassay is rising in the United States.

Presently, the escalating demand for immunoassays among the geriatric population, as they are susceptible to age-related diseases, represents one of the major factors influencing the market positively in the United States. Additionally, the increasing prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular disorders, among individuals in the country is propelling the growth of the market. Apart from this, the growing demand for personalized medicines among people is offering a positive market outlook. Moreover, the increasing focus on drug discovery is bolstering the market growth. In line with this, technological advancements, such as automated platforms and multiplexing capabilities, enhance the efficiency, sensitivity, and throughput of immunoassay systems, which is strengthening the market growth.

Furthermore, the rising need for point-of-care testing (POCT) among individuals is providing lucrative growth opportunities to industry investors in the country. In addition, increasing preferences for minimally invasive (MI) diagnostic techniques that offer reduced patient discomfort and faster results are contributing to the market growth. 

For an in-depth analysis, you can request the sample copy of the market report: https://www.imarcgroup.com/united-states-immunoassay-market/requestsample

United States Immunoassay Market Segmentation:

Technology Insights:

  • Radioimmunoassay
  • Enzyme Immunoassay
  • Rapid Test
  • Others

Product Insights:

  • Reagents and Kits
  • Analyzers/Instruments
  • Software and Services

Application Insights:

  • Therapeutic Drug Monitoring
  • Oncology
  • Cardiology
  • Endocrinology
  • Infectious Disease Testing
  • Autoimmune Diseases
  • Others

End Use Insights:

  • Hospitals
  • Blood Banks
  • Clinical Laboratories
  • Pharmaceutical and Biotech Companies
  • Academic Research Centers
  • Others

Regional Insights:

  • Northeast 
  • Midwest 
  • South 
  • West

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Ask analyst for your customized sample: https://www.imarcgroup.com/request?type=report&id=20084&flag=C

​About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

​Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-216